Univariable MR on three ANGPTL4 SNPs suggests that increased TGs conferred by ANGPTL4-mediated LPL inhibition leads to increased CAD risk (Table 4; Fig. 4F), consistent with prior studies (7, 58). Here, ANGPTL4 is linked to coronary artery disorder.